Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT ID: NCT06906341

This clinical trial is testing a new treatment approach for women with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The study will examine how effective and safe a ...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States, Centerville, Ohio, United States +21 more

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

NCT ID: NCT06824467

This clinical trial is studying a new treatment called sacituzumab tirumotecan (MK-2870) for women with platinum-sensitive recurrent ovarian cancer. The trial aims to find out if this treatment is ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Goyang Si, Kyonggi Do, Korea, Republic Of, Omaha, Nebraska, United States +27 more

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT ID: NCT05527184

This clinical trial, called IMGN151-1001, is testing a new treatment called IMGN151 for women with certain types of recurrent cancers, specifically endometrial cancer and high-grade ovarian, perito...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +37 more

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT ID: NCT05445778

The GLORIOSA clinical trial is studying a new treatment approach for patients with certain types of ovarian, fallopian tube, or peritoneal cancer who have responded well to previous platinum-based ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Columbus, Ohio, United States, Charlottesville, Virginia, United States +567 more

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

NCT ID: NCT05071937

The clinical trial titled "ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer" is studying a new combination of two medications, ZEN003694 and talazoparib, to see if they...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

A Study of XMT-1660 in Participants With Solid Tumors

NCT ID: NCT05377996

This clinical trial is studying a new treatment called XMT-1660 for patients with certain types of solid tumors, including different forms of breast cancer, ovarian cancer, and others. The main goa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Boston, Massachusetts, United States +21 more

Using Aspirin to Improve Immunological Features of Ovarian Tumors

NCT ID: NCT05080946

This clinical trial is studying whether taking aspirin alongside chemotherapy can help improve the immune response in women with ovarian, fallopian tube, or peritoneal cancer. The goal is to see if...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Tampa, Florida, United States, Portland, Oregon, United States +2 more

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

NCT ID: NCT06690775

The CATALINA-2 clinical trial is researching a new treatment called TORL-1-23 for women with advanced ovarian cancer that has not responded to platinum-based chemotherapy. This study is focused on ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States, Duarte, California, United States +22 more

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

NCT ID: NCT07024784

This clinical trial is studying a new drug called IMGN151 to see how well it works and how safe it is for treating certain gynecologic cancers, including ovarian, fallopian tube, and primary perito...

Not yet recruiting

Phase: PHASE2 Type: interventional

Personalized Timing of Interval Debulking Surgery Based on KELIM After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer - a Multicenter Randomized Phase II Non-inferiority Trial

NCT ID: NCT07023484

This clinical trial is studying a new way to decide the best timing for surgery in women with advanced ovarian or fallopian tube cancer. Usually, when surgery can’t be done right away, patients rec...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China, Hong Kong, , Hong Kong +4 more

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT ID: NCT06890338

This clinical trial is designed to evaluate the safety and effectiveness of a combination treatment using two drugs, carboplatin and mirvetuximab soravtansine (often called MIRV), for women with ad...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT ID: NCT04657068

This clinical trial is investigating a new drug called ART0380 for treating advanced or metastatic solid tumors, including types of ovarian cancer. The main goals are to find out the safest dose of...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Denver, Colorado, United States +68 more

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT ID: NCT06915025

This clinical trial is studying a new treatment called IMNN-001, which will be given directly into the abdomen along with standard chemotherapy for women who have been newly diagnosed with advanced...

Not yet recruiting

Phase: PHASE3 Type: interventional

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT ID: NCT05739981

This clinical trial, known as IMNN-001, is looking at a new treatment for women with advanced ovarian, fallopian tube, or primary peritoneal cancer. The study aims to find out if adding a drug call...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Houston, Texas, United States +1 more

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT ID: NCT05579366

This clinical trial is investigating a new drug called PRO1184 for patients with various types of advanced solid tumors, including different forms of ovarian, lung, and breast cancer. The main goal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Providence, Rhode Island, United States +42 more

Phase 1 Open-Label Study BL-M17D1 w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT ID: NCT06714617

This clinical trial is investigating a new treatment called BL-M17D1 for patients with advanced or metastatic solid tumors that have a specific protein called HER2. The study aims to evaluate how s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Indianapolis, Indiana, United States +10 more

Study of AVZO-021 in Patients With Advanced Solid Tumors

NCT ID: NCT05867251

This clinical trial is studying a new oral medication called AVZO-021, which is designed to treat patients with advanced solid tumors. The main goals of the study are to understand how safe the med...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Sarasota, Florida, United States +8 more

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

NCT ID: NCT06856499

This clinical trial is studying the safety and effectiveness of two medications, Cirtuvivint and Olaparib, for women with certain types of advanced ovarian cancer that have not responded to platinu...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Aurora, Colorado, United States, Aurora, Colorado, United States

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer

NCT ID: NCT06994195

This clinical trial is studying a new treatment called BL-B01D1 for patients with certain types of recurrent ovarian cancer that do not respond to platinum-based chemotherapy. The trial aims to see...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

NCT ID: NCT06290193

This clinical trial is researching a method called Acute Normovolemic Hemodilution (ANH) in patients with advanced ovarian cancer who are scheduled for surgery. The goal of the trial is to see if u...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +6 more

Main Menu

Clinical Trials for Fallopian Tube Cancer

60 Active Trials Found

Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

A Study of XMT-1660 in Participants With Solid Tumors

Using Aspirin to Improve Immunological Features of Ovarian Tumors

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Personalized Timing of Interval Debulking Surgery Based on KELIM After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer - a Multicenter Randomized Phase II Non-inferiority Trial

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Phase 1 Open-Label Study BL-M17D1 w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Study of AVZO-021 in Patients With Advanced Solid Tumors

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Related Conditions